Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02GGG
|
|||
| Former ID |
DIB004308
|
|||
| Drug Name |
BLI-1100
|
|||
| Indication | Acne vulgaris [ICD-11: ED80; ICD-10: L70.0; ICD-9: 706.1] | Phase 2 | [1] | |
| Company |
Braintree Laboratories Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01815450) BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.